Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7862]

Anti-cancer drug brewed from reprogrammed yeast

Anti-cancer drug brewed from reprogrammed yeast

Simple blood test predicts neurotoxic complications of CAR-T cell therapy

Simple blood test predicts neurotoxic complications of CAR-T cell therapy

Possible new cancer treatment target discovered

Possible new cancer treatment target discovered

$FDA approves pemigatinib for relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement$

FDA approves pemigatinib for relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement

FDA approves ibrutinib for paediatric patients with chronic graft versus host disease, including a new oral suspension

FDA approves ibrutinib for paediatric patients with chronic graft versus host disease, including a new oral...

Fertility preservation measures do not appear to increase the risk of breast cancer recurrence

Fertility preservation measures do not appear to increase the risk of breast cancer recurrence

Funding accelerates new approaches to vaccine development for ovarian cancer

Funding accelerates new approaches to vaccine development for ovarian cancer

Therapeutic drug renders cancer cell weapon harmless

Therapeutic drug renders cancer cell weapon harmless

Scientists discover surprise anticancer properties of common lab molecule

Scientists discover surprise anticancer properties of common lab molecule

Strategic research and development collaboration in RAS/MAPK-driven cancers announced

Strategic research and development collaboration in RAS/MAPK-driven cancers announced

More from ecancer